Models and strategies in the development of antiobesity drugs

Area of Science:

• Pharmacology
• Physiology
• Obesity Research

Background:

• Obesity is a significant global health concern, contributing to widespread morbidity and mortality.
• Current anti-obesity pharmacotherapies have limitations in efficacy and are associated with adverse effects.
• There is a critical need for the development of novel, safe, and effective anti-obesity agents.

Purpose of the Study:

• To review the physiological basis of appetite regulation.
• To discuss the utility of rodent models in the development of anti-obesity drugs.
• To identify potential future targets for novel anti-obesity agents.

Main Methods:

• Literature review of physiological mechanisms of appetite.
• Analysis of rodent models employed in anti-obesity drug development.
• Exploration of emerging therapeutic targets for obesity.

Main Results:

• Understanding of appetite regulation relies heavily on animal studies.
• Rodent models are instrumental in elucidating energy homeostasis and testing potential drug candidates.
• Several neuronal and hormonal pathways are key to regulating body weight.

Conclusions:

• Rodent models are essential for advancing the understanding of obesity and developing new treatments.
• Identifying novel targets is crucial for creating more effective anti-obesity pharmacotherapies.
• Further research into appetite regulation mechanisms can lead to improved obesity management strategies.